Investors in drug distributor AmerisourceBergen reject a challenge to CEO's $14.3M pay [View all]
Shareholders at drug distributor AmerisourceBergen lost a challenge to the chief executive’s pay package, as a proposed opioid settlement is expected to cost the company billions.
At the company’s annual meeting Thursday, investors had a chance to say whether they agreed or disagreed with the CEO’s $14.3 million compensation package for 2020 by voting on a so-called say-on-pay resolution.
CEO Steve Collis received a 26% raise and a $2.5 million cash bonus in a year when the Chesterbrook-based corporation also took a $6.6 billion hit to its books, in preparation for a potential opioid settlement with state attorneys general.
A majority of shareholders voted in favor of the pay package for Collis, the company confirmed.
Read more: https://www.inquirer.com/business/drugs/amerisourcebergen-abc-drugs-shareholders-meeting-ceo-pay-20210312.html
= new reply since forum marked as read